Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.14−0.10 (-4.46%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Biodexa Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Biodexa Pharmaceuticals's market cap was $1.32M on Nov 11, 2026, against $8.97M a year earlier. Over the last 5 years it ranged from $359.94K to $59.18B, with a median of $12.77M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.32M | -70.7% |
| 2025 | Dec 31, 2025 | $4.50M | -12.1% |
| 2024 | Dec 31, 2024 | $5.12M | +286.3% |
| 2023 | Dec 29, 2023 | $1.32M | -100.0% |
| 2022 | Dec 30, 2022 | $10.62B | -82.1% |
| 2021 | Dec 31, 2021 | $59.18B | +21481.4% |
| 2020 | Dec 31, 2020 | $274.23M | +225.4% |
| 2019 | Dec 31, 2019 | $84.27M | -47.0% |
| 2018 | Dec 31, 2018 | $159.08M | -73.7% |
| 2017 | Dec 29, 2017 | $604.22M | -61.2% |
| 2016 | Dec 30, 2016 | $1.56B | – |
See a number that looks wrong?